S-2.2, r. 2.1 - Minister’s Regulation under the Public Health Act

Full text
28. A health professional with the authority to make a diagnosis or to assess a person’s state of health and a chief executive officer of a medical biology laboratory or a clinical department of laboratory medicine must report in writing, to the competent public health director, the following infections and diseases, or pathogens that cause the infections or diseases, within 48 hours of the diagnosis, detection or characterization:
(1)  babesiosis;
(2)  brucellosis;
(3)  chancroid;
(4)  pertussis;
(5)  diphteria;
(6)  neuroinvasive arboviruses;
(7)  Q fever;
(8)  typhoid and paratyphoid fever;
(9)  granuloma inguinale;
(10)  viral hepatitis;
(11)  Chlamydia trachomatis infection;
(12)  Hantavirus infection;
(13)  Plasmodium infection;
(14)  gonococcal infection;
(15)  invasive Haemophilus influenzae infection;
(16)  invasive meningococcal infection;
(17)  invasive group A streptococcal infection;
(18)  invasive Streptococcus pneumoniae infection;
(19)  West Nile virus infection;
(20)  Legionnaire’s disease;
(21)  leprosy;
(22)  lymphogranuloma venereum;
(23)  Chagas disease;
(24)  Lyme disease;
(25)  mumps;
(26)  poliomyelitis;
(27)  psittacosis;
(28)  rabies;
(29)  measles;
(30)  rubella;
(31)  severe acute respiratory syndrome (SARS);
(32)  syphilis;
(33)  tetanus;
(34)  trichinosis;
(35)  tuberculosis;
(36)  tularaemia;
(37)  typhus.
2019-012M.O. 2019-012, s. 28; S.Q. 2020, c. 6, s. 73.
28. A physician and a chief executive officer of a medical biology laboratory or a clinical department of laboratory medicine must report in writing, to the competent public health director, the following infections and diseases, or pathogens that cause the infections or diseases, within 48 hours of the diagnosis, detection or characterization:
(1)  babesiosis;
(2)  brucellosis;
(3)  chancroid;
(4)  pertussis;
(5)  diphteria;
(6)  neuroinvasive arboviruses;
(7)  Q fever;
(8)  typhoid and paratyphoid fever;
(9)  granuloma inguinale;
(10)  viral hepatitis;
(11)  Chlamydia trachomatis infection;
(12)  Hantavirus infection;
(13)  Plasmodium infection;
(14)  gonococcal infection;
(15)  invasive Haemophilus influenzae infection;
(16)  invasive meningococcal infection;
(17)  invasive group A streptococcal infection;
(18)  invasive Streptococcus pneumoniae infection;
(19)  West Nile virus infection;
(20)  Legionnaire’s disease;
(21)  leprosy;
(22)  lymphogranuloma venereum;
(23)  Chagas disease;
(24)  Lyme disease;
(25)  mumps;
(26)  poliomyelitis;
(27)  psittacosis;
(28)  rabies;
(29)  measles;
(30)  rubella;
(31)  severe acute respiratory syndrome (SARS);
(32)  syphilis;
(33)  tetanus;
(34)  trichinosis;
(35)  tuberculosis;
(36)  tularaemia;
(37)  typhus.
2019-012M.O. 2019-012, s. 28.
In force: 2019-10-17
28. A physician and a chief executive officer of a medical biology laboratory or a clinical department of laboratory medicine must report in writing, to the competent public health director, the following infections and diseases, or pathogens that cause the infections or diseases, within 48 hours of the diagnosis, detection or characterization:
(1)  babesiosis;
(2)  brucellosis;
(3)  chancroid;
(4)  pertussis;
(5)  diphteria;
(6)  neuroinvasive arboviruses;
(7)  Q fever;
(8)  typhoid and paratyphoid fever;
(9)  granuloma inguinale;
(10)  viral hepatitis;
(11)  Chlamydia trachomatis infection;
(12)  Hantavirus infection;
(13)  Plasmodium infection;
(14)  gonococcal infection;
(15)  invasive Haemophilus influenzae infection;
(16)  invasive meningococcal infection;
(17)  invasive group A streptococcal infection;
(18)  invasive Streptococcus pneumoniae infection;
(19)  West Nile virus infection;
(20)  Legionnaire’s disease;
(21)  leprosy;
(22)  lymphogranuloma venereum;
(23)  Chagas disease;
(24)  Lyme disease;
(25)  mumps;
(26)  poliomyelitis;
(27)  psittacosis;
(28)  rabies;
(29)  measles;
(30)  rubella;
(31)  severe acute respiratory syndrome (SARS);
(32)  syphilis;
(33)  tetanus;
(34)  trichinosis;
(35)  tuberculosis;
(36)  tularaemia;
(37)  typhus.
2019-012M.O. 2019-012, s. 28.